[HTML][HTML] Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder

L Bartova, G Fugger, M Dold, A Kautzky… - Journal of affective …, 2023 - Elsevier
Background Serotonin-norepinephrine reuptake inhibitors (SNRIs) are among the most
frequently prescribed antidepressants (ADs) for major depressive disorder (MDD), with an …

Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusions

W Zheng, LM Gu, XH Yang, YL Zhou… - … Journal of Psychiatry …, 2023 - Taylor & Francis
Objectives Accumulating evidence suggests that the effects of ketamine administered
intravenously at subanaesthetic doses on both anhedonic symptoms and suicidal ideation …